AS
CPRX icon

Altshuler Shaham’s Catalyst Pharmaceutical CPRX Stock Holding History

Altshuler Shaham’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,607
Closed -$67.1K – 398
2022
Q4 		$67.1K Sell
3,607
-441
-11% -$6.79K ﹤0.01% 176
2022
Q3 		$51K Sell
4,048
-5,460
-57% -$64.7K ﹤0.01% 214
2022
Q2 		$67K Buy
9,508
+4,543
+92% +$33.3K ﹤0.01% 197
2022
Q1 		$41K Sell
4,965
-1,797
-27% -$12.7K ﹤0.01% 397
2021
Q4 		$46K Sell
6,762
-2,799
-29% -$18.4K ﹤0.01% 445
2021
Q3 		$51K Sell
9,561
-9,499
-50% -$51.9K ﹤0.01% 405
2021
Q2 		$110K Buy
+19,060
New +$98.4K ﹤0.01% 313

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Altshuler Shaham's CPRX Position: Q1 2023 in Review

Altshuler Shaham sold out of Catalyst Pharmaceutical (CPRX) in Q1 2023, closing a stake of 3,607 shares — an estimated $67.1K sold.

Altshuler Shaham first reported a position in CPRX in Q2 2021 and held it in 7 quarters. The position peaked at $110K in Q2 2021. 259 funds tracked by Wall St. Rank hold CPRX as of Q1 2023.

  • Altshuler Shaham reported no remaining Catalyst Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Altshuler Shaham sold 3,607 Catalyst Pharmaceutical shares in Q1 2023, an estimated $67.1K.
  • Altshuler Shaham first reported a position in Catalyst Pharmaceutical in Q2 2021 and held it in 7 quarters.
  • Altshuler Shaham's Catalyst Pharmaceutical position peaked at $110K in Q2 2021.
  • 259 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2023.

Based on Altshuler Shaham's 13F filing for Q1 2023, filed 9 May 2023.